AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
EMICIZUMAB in Zimbabwe
4 products registered with MCAZ — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| HEMLIBRA SOLUTION; INJECTION | 2019/10/5815 | ROCHE PRODUCTS (PTY) LTD | active | 15 Jan 2029 |
| HEMLIBRA SOLUTION; INJECTION | 2019/10/5812 | ROCHE PRODUCTS (PTY) LTD | active | 15 Jan 2029 |
| HEMLIBRA SOLUTION; INJECTION | 2019/10/5813 | ROCHE PRODUCTS (PTY) LTD | active | 15 Jan 2029 |
| HEMLIBRA SOLUTION; INJECTION | 2019/10/5814 | ROCHE PRODUCTS (PTY) LTD | active | 15 Jan 2029 |
EMICIZUMAB — MCAZ Registration Details
MCAZ (Zimbabwe) has 4 registered products containing EMICIZUMAB, of which 4 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track EMICIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.